top of page

Wizbiosolution's executives and research experts have the expertise and business acumen to lead changes in point-of-care diagnostics through innovative ideas.

현영_122s.png

Wizbiosolutions Inc. was established in 2018 and has grown into a vibrant healthcare diagnostics company through steady innovation and growth in the field of molecular diagnostics.

We at Wizbiosolutions aim to become a global healthcare diagnostics company based on three key management philosophies: open communication, quality management, and creation of value for our customers, shareholders and employees.

In addition, we aim to contribute to the prevention and diagnosis of human diseases through the development of innovative technologies and unique diagnostic solutions required for POCT diagnosis by continued new ideas, innovations and solutions.

Today and in the future, Wizbiosolutions is committed to contributing to a healthier and safer life for mankind by providing expertise, innovation and relevant solutions in the field of molecular diagnostics.

Thank you all,

Hyun Young, LEE

Founder

Chief Executive Officer

  • Point-of-care molecular diagnostics expert

  • Over 20 years of experience in the in vitro diagnostic industry (specifically molecular diagnostics)

  • Company management for more than 10 years

류진_11s.png

Jin, YEW

Vice President

MBA

  • Company management expert.

  • Over 20 years of experience in brand and marketing strategy in global companies. 

  • More than 10-years in global company’s management as director and country manager.

서창일_11s.png
  • Worked as a research and development manager for a biotechnology company for over 20 years.

  • Worked as a research professor at a medical school

  • Conducted multiple research projects related to biology.

Chang Il, SUH

Chief Technology Officer

Director | Biotech Institute

PhD

Kook Nyung, LEE

Director | IVD Device Institute

PhD

이국녕_11s.png
  • Nanobiosensors and IVD device expert.

  • R&D experience in IVD devices and biosensors over 20 years in KETI and SNU.

  • Technology transfers over 5 cases to companies in biosensor fields.

bottom of page